Cargando…

The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database

OBJECTIVES: The aim of this study was to evaluate changes in the uptake of intrathecal baclofen (ITB) following commissioning of this therapy by the National Health Service (NHS) England in April 2013. The specific objectives of this study were: (i) to explore the gap between the need for and the ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Narendran, Rajesh C, Duarte, Rui V, Valyi, Andrea, Eldabe, Sam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486968/
https://www.ncbi.nlm.nih.gov/pubmed/26129634
http://dx.doi.org/10.1136/bmjopen-2014-007517
_version_ 1782378948985880576
author Narendran, Rajesh C
Duarte, Rui V
Valyi, Andrea
Eldabe, Sam
author_facet Narendran, Rajesh C
Duarte, Rui V
Valyi, Andrea
Eldabe, Sam
author_sort Narendran, Rajesh C
collection PubMed
description OBJECTIVES: The aim of this study was to evaluate changes in the uptake of intrathecal baclofen (ITB) following commissioning of this therapy by the National Health Service (NHS) England in April 2013. The specific objectives of this study were: (i) to explore the gap between the need for and the actual provision of ITB services; and (ii) to compare England figures with other European countries with comparable data available. SETTING: Data for ITB -related procedures were obtained from the Hospital Episode Statistics (HES) database from 2009/2010 to 2013/2014. PARTICIPANTS: Patients receiving ITB for the management of spasticity. RESULTS: The available data for implantation of ITB from 2009/2010 to 2013/2014 for the treatment of spasticity due to varied aetiologies show that there has not been an increase in uptake of this therapy. The estimated need for this treatment based on the incidence and prevalence of conditions susceptible to ITB therapy is between 4.6 and 5.7 per million population. Our analysis of the data available from the HES database showed that the actual number of implants is around 3.0 per million population. The same period 2009–2014 has seen an increase in the delivery of other neuromodulation techniques including spinal cord stimulation, deep brain stimulation and sacral nerve stimulation. CONCLUSIONS: There is a considerable gap between the need for and provision of ITB figures nationally. Additionally, within the same area, we have observed important differences in the ITB service delivery between the various trusts. The reasons for this can be multifactorial, including individual experience and opinions, organisational structures, resource and financial limitations. Further research analysing the efficacy and cost-effectiveness of this treatment in the UK might inform the development of Technology Appraisal Guidance for ITB, potentially leading to an improvement in service provision.
format Online
Article
Text
id pubmed-4486968
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-44869682015-07-20 The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database Narendran, Rajesh C Duarte, Rui V Valyi, Andrea Eldabe, Sam BMJ Open Rehabilitation Medicine OBJECTIVES: The aim of this study was to evaluate changes in the uptake of intrathecal baclofen (ITB) following commissioning of this therapy by the National Health Service (NHS) England in April 2013. The specific objectives of this study were: (i) to explore the gap between the need for and the actual provision of ITB services; and (ii) to compare England figures with other European countries with comparable data available. SETTING: Data for ITB -related procedures were obtained from the Hospital Episode Statistics (HES) database from 2009/2010 to 2013/2014. PARTICIPANTS: Patients receiving ITB for the management of spasticity. RESULTS: The available data for implantation of ITB from 2009/2010 to 2013/2014 for the treatment of spasticity due to varied aetiologies show that there has not been an increase in uptake of this therapy. The estimated need for this treatment based on the incidence and prevalence of conditions susceptible to ITB therapy is between 4.6 and 5.7 per million population. Our analysis of the data available from the HES database showed that the actual number of implants is around 3.0 per million population. The same period 2009–2014 has seen an increase in the delivery of other neuromodulation techniques including spinal cord stimulation, deep brain stimulation and sacral nerve stimulation. CONCLUSIONS: There is a considerable gap between the need for and provision of ITB figures nationally. Additionally, within the same area, we have observed important differences in the ITB service delivery between the various trusts. The reasons for this can be multifactorial, including individual experience and opinions, organisational structures, resource and financial limitations. Further research analysing the efficacy and cost-effectiveness of this treatment in the UK might inform the development of Technology Appraisal Guidance for ITB, potentially leading to an improvement in service provision. BMJ Publishing Group 2015-06-30 /pmc/articles/PMC4486968/ /pubmed/26129634 http://dx.doi.org/10.1136/bmjopen-2014-007517 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Rehabilitation Medicine
Narendran, Rajesh C
Duarte, Rui V
Valyi, Andrea
Eldabe, Sam
The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database
title The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database
title_full The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database
title_fullStr The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database
title_full_unstemmed The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database
title_short The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database
title_sort need for and provision of intrathecal baclofen therapy for the management of spasticity in england: an assessment of the hospital episode statistics database
topic Rehabilitation Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486968/
https://www.ncbi.nlm.nih.gov/pubmed/26129634
http://dx.doi.org/10.1136/bmjopen-2014-007517
work_keys_str_mv AT narendranrajeshc theneedforandprovisionofintrathecalbaclofentherapyforthemanagementofspasticityinenglandanassessmentofthehospitalepisodestatisticsdatabase
AT duarteruiv theneedforandprovisionofintrathecalbaclofentherapyforthemanagementofspasticityinenglandanassessmentofthehospitalepisodestatisticsdatabase
AT valyiandrea theneedforandprovisionofintrathecalbaclofentherapyforthemanagementofspasticityinenglandanassessmentofthehospitalepisodestatisticsdatabase
AT eldabesam theneedforandprovisionofintrathecalbaclofentherapyforthemanagementofspasticityinenglandanassessmentofthehospitalepisodestatisticsdatabase
AT narendranrajeshc needforandprovisionofintrathecalbaclofentherapyforthemanagementofspasticityinenglandanassessmentofthehospitalepisodestatisticsdatabase
AT duarteruiv needforandprovisionofintrathecalbaclofentherapyforthemanagementofspasticityinenglandanassessmentofthehospitalepisodestatisticsdatabase
AT valyiandrea needforandprovisionofintrathecalbaclofentherapyforthemanagementofspasticityinenglandanassessmentofthehospitalepisodestatisticsdatabase
AT eldabesam needforandprovisionofintrathecalbaclofentherapyforthemanagementofspasticityinenglandanassessmentofthehospitalepisodestatisticsdatabase